Keywords
leukocytes
peripheral blood
thrombin
How to Cite
Abstract
The experimental study was conducted on 72 adult male WAG laboratory rats weighing 180–200 g. The study was conducted in accordance with the guidelines of Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes. Intact rats served as a control for the natural course of inflammation, and rats receiving dabigatran etexilate without further induction of chronic inflammation served as a control for inflammation in the setting of dabigatran etexilate administration. The model of inflammation was carrageenan secondary chronic aseptic inflammation, which was induced by intramuscular injection of 10 mg λ-carrageenan (Sigma, USA) dissolved in 1 ml of isotonic sodium chloride solution into the right thigh. Dabigatran etexilate was administered intragastrically through a gavage tube at a dose of 15 mg/kg/day dissolved in 1 ml of isotonic sodium chloride solution daily throughout the experiment, which lasted 28 days. The results of the study have shown that the use of a thrombin blocker dabigatran etexilate, compared with the natural course of secondary chronic carrageenan inflammation, promotes the involvement of leukocytes on the 14th day, which leads to greater elimination of phlogogen during this period, and a decrease in the number of leukocytes on the 21st and 28th days during the period of chronic inflammation, which indicates a decrease in the need for leukocytes in these periods. The tendency to increase the number of segmented neutrophils by 1.3 times on the 28th day of inflammation after administration of dabigatran etexilate, compared with the natural course of inflammation, indicates a less pronounced emigration of leukocytes to the inflammatory focus due to a decrease in the intensity of chronic inflammation. A decrease in the number of banded neutrophils in the peripheral blood on the 28th day may be associated with a decrease in their emigration to the inflammatory focus. A significant decrease in the number of monocytes by 1.62 times (p<0.01) on the 28th day indicates that the use of the thrombin blocker dabigatran etexilate reduces leukocyte adhesion and reduces the chronicity of inflammation.
Keywords: toxic action, biochemical variant, antimicrobials.
References
Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771-6. DOI: 10.1016/j.cell.2010.03.006. PMID: 20303867.
Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 2007;147(2):227-35. DOI: 10.1111/j.1365-2249.2006.03261.x. PMID: 17223962.
Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871-82. DOI: 10.1016/j.cell.2010.02.029. PMID: 20303877.
Zhou Y, Hong Y, Huang H. Triptolide Attenuates Inflammatory Response in Membranous Glomerulonephritis Rat via Downregulation of NF-kappaB Signaling Pathway. Kidney and Blood Press Res. 2016;41(6):901-10. DOI: 10.1159/000452591. PMID: 27871079.
Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. DOI: 10.1101/cshperspect.a001651. PMID: 20457564.
Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007;127(5):1009-17. DOI: 10.1038/sj.jid.5700811. PMID: 17435786.
Van Linthout S, Miteva K, Tschope C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res. 2014;102(2):258-69. DOI: 10.1093/cvr/cvu062. PMID: 24728497.
Robb CT, Regan KH, Dorward DA, Rossi AG. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol. 2016;38(4):425-48. DOI: 10.1007/s00281-016-0560-6. PMID: 27116944.
Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173-82. DOI: 10.1038/nri1785. PMID: 16498448.
Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction. 2009;138(6):903-19. DOI: 10.1530/REP-09-0247. PMID: 19793840.
Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281-6. DOI: 10.2174/1568010054022024. PMID: 16101534.
Huang C, Sali A, Stevens RL. Regulation and function of mast cell proteases in inflammation. J Clin Immunol. 1998;18(3):169-83. DOI: 10.1023/a:1020574820797. PMID: 9624576.
Aggrey AA, Srivastava K, Ture S, Field DJ, Morrell CN. Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria. J Immunol. 2013;190(9):4685-91. DOI: 10.4049/jimmunol.1202672. PMID: 23536632.
Headland SE, Norling LV. The resolution of inflammation: Principles and challenges. Semin Immunol. 2015;27(3):149-60. DOI: 10.1016/j.smim.2015.03.014. PMID: 25911383.
Reville K, Crean JK, Vivers S, Dransfield I, Godson C. Lipoxin A4 redistributes myosin IIA, Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes. J Immunol. 2006;176(3):1878-88. DOI: 10.4049/jimmunol.176.3.1878. PMID: 16424219.
Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191-7. DOI: 10.1038/ni1276. PMID: 16369558. Link?
Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH. T cells in vascular inflammatory diseases. Front Immunol. 2014;5:504. DOI: 10.3389/fimmu.2014.00504. PMID: 25352848.
Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol. 2016;7:160. DOI: 10.3389/fimmu.2016.00160. PMID: 27199985.
Radhakrishnan R, Moore SA, Sluka KA. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain. 2003;104(3):567-77. DOI: 10.1016/S0304-3959(03)00114-3. PMID: 12927629.
Dittmeier M, Wassmuth K, Schuhmann MK, Kraft P, Kleinschnitz C, Fluri F. Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke. Curr Neurovasc Res. 2016;13(3):199-206. DOI: 10.2174/1567202613666160517122605. PMID: 27184031.
Durmaz S, Kurtoglu T, Rahman OF, Tataroglu C, Yılmaz M, Barbarus E, Erkan MH. Direct oral anticoagulant agents attenuate temporary aortic occlusion-induced renal oxidative and inflammatory responses in rats. Turk Gogus Kalp Damar Cerrahisi Derg. 2022;30(2):184-91. DOI: 10.5606/tgkdc.dergisi.2022.22831. PMID: 36168569.
Vogler GA. Anesthesia and Analgesia. Chapter 19. In: Suckow MA, Weisbroth SH, Franklin CL. (eds.). The Laboratory Rat. Second Edition. Burlington: Academic Press; 2006. P. 627-64. DOI: 10.1016/B978-012074903-4/50022-4.
Abdi-Azar H, Abbasi-Maleki S. Comparison of the anesthesia with thiopental sodium alone and their combination with Citrus aurantium L. (Rutaseae) essential oil in male rat. Bull Env Pharmacol Life Sci. 2014;3(Spl Issue V):37-44. Available at: https://bepls.com/spl_v_2014/8.pdf
Mishra P, Singh U, Pandey CM, Mishra P, Pandey G. Application of Student's t-test, analysis of variance, and covariance. Ann Card Anaesth. 2019;22(4):407-11. DOI: 10.4103/aca.ACA_94_19. PMID: 31621677.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.